133 related articles for article (PubMed ID: 22487931)
21. The effects of microporosity on osteoinduction of calcium phosphate bone graft substitute biomaterials.
Chan O; Coathup MJ; Nesbitt A; Ho CY; Hing KA; Buckland T; Campion C; Blunn GW
Acta Biomater; 2012 Jul; 8(7):2788-94. PubMed ID: 22475784
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory response and bone healing capacity of two porous calcium phosphate ceramics in critical size cortical bone defects.
Chatterjea A; van der Stok J; Danoux CB; Yuan H; Habibovic P; van Blitterswijk CA; Weinans H; de Boer J
J Biomed Mater Res A; 2014 May; 102(5):1399-407. PubMed ID: 23733500
[TBL] [Abstract][Full Text] [Related]
23. Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation.
Janicki P; Kasten P; Kleinschmidt K; Luginbuehl R; Richter W
Acta Biomater; 2010 Aug; 6(8):3292-301. PubMed ID: 20123138
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vivo study of six hydroxyapatite-based bone graft substitutes.
Habibovic P; Kruyt MC; Juhl MV; Clyens S; Martinetti R; Dolcini L; Theilgaard N; van Blitterswijk CA
J Orthop Res; 2008 Oct; 26(10):1363-70. PubMed ID: 18404698
[TBL] [Abstract][Full Text] [Related]
25. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
Takahashi Y; Yamamoto M; Tabata Y
Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
[TBL] [Abstract][Full Text] [Related]
26. Fabrication of low-crystallinity hydroxyapatite foam based on the setting reaction of alpha-tricalcium phosphate foam.
Karashima S; Takeuchi A; Matsuya S; Udoh K; Koyano K; Ishikawa K
J Biomed Mater Res A; 2009 Mar; 88(3):628-33. PubMed ID: 18314899
[TBL] [Abstract][Full Text] [Related]
27. [Bone inductive activity of beta-tricalcium phosphate-bone morphogenetic protein complex].
Mieki A
Aichi Gakuin Daigaku Shigakkai Shi; 1990 Mar; 28(1 Pt 1):43-58. PubMed ID: 2135110
[TBL] [Abstract][Full Text] [Related]
28. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
E LL; Xu LL; Wu X; Wang DS; Lv Y; Wang JZ; Liu HC
Tissue Eng Part A; 2010 Sep; 16(9):2927-40. PubMed ID: 20486786
[TBL] [Abstract][Full Text] [Related]
29. Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.
Han D; Sun X; Zhang X; Tang T; Dai K
Connect Tissue Res; 2008; 49(5):343-50. PubMed ID: 18991087
[TBL] [Abstract][Full Text] [Related]
30. Substrate geometry directs the in vitro mineralization of calcium phosphate ceramics.
Bianchi M; Urquia Edreira ER; Wolke JG; Birgani ZT; Habibovic P; Jansen JA; Tampieri A; Marcacci M; Leeuwenburgh SC; van den Beucken JJ
Acta Biomater; 2014 Feb; 10(2):661-9. PubMed ID: 24184857
[TBL] [Abstract][Full Text] [Related]
31. The effect of the microstructure of beta-tricalcium phosphate on the metabolism of subsequently formed bone tissue.
Okuda T; Ioku K; Yonezawa I; Minagi H; Kawachi G; Gonda Y; Murayama H; Shibata Y; Minami S; Kamihira S; Kurosawa H; Ikeda T
Biomaterials; 2007 Jun; 28(16):2612-21. PubMed ID: 17316789
[TBL] [Abstract][Full Text] [Related]
32. Surface modification of PCL-TCP scaffolds improve interfacial mechanical interlock and enhance early bone formation: an in vitro and in vivo characterization.
Yeo A; Wong WJ; Khoo HH; Teoh SH
J Biomed Mater Res A; 2010 Jan; 92(1):311-21. PubMed ID: 19189386
[TBL] [Abstract][Full Text] [Related]
33. Bone bonding mechanism of beta-tricalcium phosphate.
Kotani S; Fujita Y; Kitsugi T; Nakamura T; Yamamuro T; Ohtsuki C; Kokubo T
J Biomed Mater Res; 1991 Oct; 25(10):1303-15. PubMed ID: 1812121
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness of the controlled release of simvastatin from β-TCP macrosphere in the treatment of OVX mice.
Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B
J Tissue Eng Regen Med; 2016 Mar; 10(3):E195-203. PubMed ID: 23784984
[TBL] [Abstract][Full Text] [Related]
35. Influence of TiO2 and Ag2O addition on tricalcium phosphate ceramics.
Seeley Z; Bandyopadhyay A; Bose S
J Biomed Mater Res A; 2007 Jul; 82(1):113-21. PubMed ID: 17269142
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect.
Rojbani H; Nyan M; Ohya K; Kasugai S
J Biomed Mater Res A; 2011 Sep; 98(4):488-98. PubMed ID: 21681941
[TBL] [Abstract][Full Text] [Related]
37. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs.
Lee JS; Wikesjö UM; Jung UW; Choi SH; Pippig S; Siedler M; Kim CK
J Clin Periodontol; 2010 Apr; 37(4):382-9. PubMed ID: 20447262
[TBL] [Abstract][Full Text] [Related]
38. Effect of water glass coating of tricalcium phosphate granules on in vivo bone formation.
Ryu SM; Ahn MW; Park CH; Lee GW; Song IH; Ahn HS; Kim J; Kim S
J Biomater Appl; 2018 Nov; 33(5):662-672. PubMed ID: 30396326
[TBL] [Abstract][Full Text] [Related]
39. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier.
Kasten P; Vogel J; Luginbühl R; Niemeyer P; Tonak M; Lorenz H; Helbig L; Weiss S; Fellenberg J; Leo A; Simank HG; Richter W
Biomaterials; 2005 Oct; 26(29):5879-89. PubMed ID: 15913762
[TBL] [Abstract][Full Text] [Related]
40. [Application of elemental microanalysis for estimation of osteoinduction and osteoconduction of hydroxyapatite bone implants].
Dawidowicz A; Pielka S; Paluch D; Kuryszko J; Staniszewska-Kuś J; Solski L
Polim Med; 2005; 35(1):3-14. PubMed ID: 16050072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
